NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
28/03/2023
Voltar para busca
Dado oficial do USPTO
M MYDECINE INNOVATIONS GROUP
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
20
Atualização mais recente
28/03/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
42, 44
Data de depósito
01/03/2022
Data de registro
28/03/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/03/2023
Última transação
28/03/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Primeiro uso
01/04/2020
Primeiro uso no comércio
01/04/2020
Código do desenho
3
Tipo de titular
03
Localização do titular
Denver, CO
Examinador
LAVOIE, RYAN
Unidade examinadora
L80
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording "MYDECINE INNOVATIONS GROUP" in stylized font to the right of a stylized "M" surrounded by stylized shapes inside of a circle carrier.
Titulares e representantes
Titulares
Mydecine Innovations Group Inc
Representantes
Tyler K Berger Berger Law Firm, PLLC
Classificação técnica
Classes Nice
Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Biological research; Biological research and analysis; Biomedical research services; Chemical, biochemical, biological and bacteriological research and analysis; Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of pharmacogenetics; Development of pharmaceutical preparations and medicines; Genetic testing for scientific research purposes; Laboratory research in the field of mental health; Laboratory research in the field of mycology; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of mental health; Medical and scientific research in the field of mycology; Medical and scientific research, namely, conducting clinical trials for others; Medical laboratory services; Medical research; Medical research services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research services; Product research and development; Providing information about medical and scientific research; Providing information about medical research; Providing information about medical research in the field of mental health; Providing information about medical research in the field of mycology; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Quality control for others; Research and development in the field of mental health; Research and development in the field of mycology; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of new products for others; Research and development of technology in the field of mental health; Research and development of technology in the field of mycology; Research and development of vaccines and medicines; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific and technological services, namely, research and design in the field of mental health; Scientific and technological services, namely, research and design in the field of mycology; Scientific and technological services, namely, scientific research, analysis, testing in the field of medical information, medical diagnostics, healthcare, computer technology, public health, and public health research in the field of mental health; Scientific and technological services, namely, scientific research, analysis, testing in the field of medical information, medical diagnostics, healthcare, computer technology, public health, and public health research in the field of mycology; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research and development; Scientific research in the field of genetics and genetic engineering; Scientific research in the nature of conducting clinical trials for others in the field of mental health; Scientific research in the nature of conducting clinical trials for others in the field of mycology; Testing of pharmaceuticals
Classe 44
Psychotherapy; Addiction treatment services; Advisory services relating to health care; Advisory services relating to health; Alternative medicine services; Clinical mental health counseling services; Consultancy services relating to health care; Drug use testing services; Health care; Health care consulting in the field of mental health; Health care services for treating mental health; Health care services, namely, providing a database in the field of mental health information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Health care services, namely, providing a database in the field of mycology information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Health care services, namely, pharmaceutical drug development services, medical research, biological research, product research and development and pharmaceutical research services; Health clinic services; Managed health care services; Medical services; Mental health services; Mental health therapy services; Providing mental health and wellness information; Psychotherapy services
Publicações
Histórico de despachos e eventos da marca no USPTO.
20 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
28/03/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/03/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/03/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/03/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/01/2023
PUBO
PUBLISHED FOR OPPOSITION
10/01/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/12/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/12/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
05/12/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/12/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
05/12/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/12/2022
DOCK
ASSIGNED TO EXAMINER
30/11/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
25/05/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
25/05/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25/05/2022
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/03/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/03/2022
NWAP
NEW APPLICATION ENTERED
04/03/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace M MYDECINE INNOVATIONS GROUP ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.